| LncRNA GClnc1 promotes gastric carcinogenesis and may act as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern TT Sun, J He, Q Liang, LL Ren, TT Yan, TC Yu, JY Tang, YJ Bao, Y Hu, ... Cancer discovery 6 (7), 784-801, 2016 | 359 | 2016 |
| Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer Y Hu, J Wang, J Qian, X Kong, J Tang, Y Wang, H Chen, J Hong, W Zou, ... Cancer research 74 (23), 6890-6902, 2014 | 285 | 2014 |
| A long non-coding RNA signature to improve prognosis prediction of colorectal cancer Y Hu, HY Chen, CY Yu, J Xu, JL Wang, J Qian, X Zhang, JY Fang Oncotarget 5 (8), 2230, 2014 | 161 | 2014 |
| Unequal prognostic potentials of p53 gain-of-function mutations in human cancers associate with drug-metabolizing activity J Xu, J Wang, Y Hu, J Qian, B Xu, H Chen, W Zou, JY Fang Cell death & disease 5 (3), e1108-e1108, 2014 | 116 | 2014 |
| Candidate microRNA biomarkers in human gastric cancer: a systematic review and validation study JL Wang, Y Hu, X Kong, ZH Wang, HY Chen, J Xu, JY Fang PloS one 8 (9), e73683, 2013 | 95 | 2013 |
| Long Noncoding RNA GCASPC, a Target of miR-17-3p, Negatively Regulates Pyruvate Carboxylase–Dependent Cell Proliferation in Gallbladder Cancer M Ma, Y Zhang, M Weng, S Wang, Y Hu, Z Hou, Y Qin, W Gong, YJ Zhang, ... Cancer research 76 (18), 5361-5371, 2016 | 93 | 2016 |
| MicroRNA sequence polymorphisms and the risk of different types of cancer Y Hu, CY Yu, JL Wang, J Guan, HY Chen, JY Fang Scientific reports 4 (1), 3648, 2014 | 86 | 2014 |
| OCT1 is a determinant of synbindin-related ERK signalling with independent prognostic significance in gastric cancer J Qian, X Kong, N Deng, P Tan, H Chen, J Wang, Z Li, Y Hu, W Zou, J Xu, ... Gut 64 (1), 37-48, 2015 | 75 | 2015 |
| RhoGAPs attenuate cell proliferation by direct interaction with p53 tetramerization domain J Xu, X Zhou, J Wang, Z Li, X Kong, J Qian, Y Hu, JY Fang Cell reports 3 (5), 1526-1538, 2013 | 73 | 2013 |
| ArhGAP30 promotes p53 acetylation and function in colorectal cancer J Wang, J Qian, Y Hu, X Kong, H Chen, Q Shi, L Jiang, C Wu, W Zou, ... Nature communications 5 (1), 4735, 2014 | 70 | 2014 |
| Heterogeneity of Li-Fraumeni syndrome links to unequal gain-of-function effects of p53 mutations J Xu, J Qian, Y Hu, J Wang, X Zhou, H Chen, JY Fang Scientific reports 4 (1), 4223, 2014 | 69 | 2014 |
| lncRNA GCAWKR promotes gastric cancer development by scaffolding the chromatin modification factors WDR5 and KAT2A M Ma, Y Zhang, M Weng, Y Hu, Y Xuan, YR Hu, K Lv Molecular Therapy 26 (11), 2658-2668, 2018 | 46 | 2018 |
| Recurrence‐associated gene signature optimizes recurrence‐free survival prediction of colorectal cancer X Tian, X Zhu, T Yan, C Yu, C Shen, Y Hu, J Hong, H Chen, JY Fang Molecular oncology 11 (11), 1544-1560, 2017 | 42 | 2017 |
| Can the incidence of gastric cancer be reduced in the new century? Y Hu, JY Fang, SD Xiao Journal of digestive diseases 14 (1), 11-15, 2013 | 33 | 2013 |
| Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome Y Zhang, Y Hu, JY Fang, J Xu Oncotarget 7 (10), 11056, 2016 | 32 | 2016 |
| Proteomic identification of ERP29 as a key chemoresistant factor activated by the aggregating p53 mutant Arg282Trp Y Zhang, Y Hu, JL Wang, H Yao, H Wang, L Liang, C Li, H Shi, Y Chen, ... Oncogene 36 (39), 5473-5483, 2017 | 27 | 2017 |
| Roles of competing endogenous RNAs in gastric cancer Y Hu, H Tian, J Xu, JY Fang Briefings in functional genomics 15 (3), 266-273, 2016 | 27 | 2016 |
| A designed peptide targets two types of modifications of p53 with anti-cancer activity L Liang, H Wang, H Shi, Z Li, H Yao, Z Bu, N Song, C Li, D Xiang, ... Cell chemical biology 25 (6), 761-774. e5, 2018 | 18 | 2018 |
| Are epithelial ovarian cancers of the mesenchymal subtype actually intraperitoneal metastases to the ovary? Y Hu, B Taylor-Harding, Y Raz, M Haro, MS Recouvreux, E Taylan, ... Frontiers in cell and developmental biology 8, 647, 2020 | 16 | 2020 |
| Exosome and secretion: action on? Y Hu, R Zhang, G Chen Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms …, 2020 | 16 | 2020 |
